openPR Logo
Press release

Multi-Infarct Dementia Market Estimated to Expand at a Robust CAGR by 2020

03-20-2018 11:33 AM CET | Health & Medicine

Press release from: Transparency Market Research

Multi-Infarct Dementia Market Estimated to Expand at a Robust

Multi-infarct dementia (MID) is one of the common causes of memory loss among elderly people as a result of reduced blood flow to parts of the brain. The primary reason for multi-infarct dementia is a series of minor strokes resulting in disruption of blood flow leading towards the brain. Since this medical condition arises due to problematic vessels, it is also known as vascular dementia (VaD). Multi-infarct dementia commonly affects people of age group 55 to 75 years. According to the National Institutes of Health, multi-infarct dementia is the second leading form of dementia, accounting for up to 20% of all cases dementia cases in people above age 65. An integrative approach to diagnosis of multi-infarct dementia is recommended which involves symptoms, medical history, health and lifestyle and certain cognitive tests in order to assess person’s cognitive ability. A specialist doctor may look for blood pressure, cholesterol levels, an electrocardiograph, etc to support a diagnosis of multi-infarct dementia. Imaging techniques such as computed tomography (CT scan) or a magnetic resonance imaging scan (MRI)

Presently, there is no treatment available to reverse the damage of brain cells that has been occurred due to stroke. Therefore, the multi-infarct dementia or vascular dementia therapy largely focuses on prevention of future strokes through controlling or avoiding conditions and diseases which increase the risk of stroke. The pharmacological treatment for multi-infarct dementia (MID) includes cholinesterase inhibitors (ChEIs) such as donepezil, galantamine, and rivastigmine. Rivastigmine is a second generation cholinesterase inhibitor with the capacity to inhibit both acetylcholinesterase and butyrylcholinesterase. Other promising pharmacological medications prescribed for management of multi-infarct dementia include memantine, nimodipine, hydergine, folic acid and Cytidine 5′-Diphosphocholine (CDP-choline). Other classes of drugs utilized to treat multi-infarct dementia include selective serotonin reuptake inhibitors (SSRIs), calcium channel blockers (CCBs) and angiotensin-converting-enzyme inhibitors (ACE inhibitors).

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3451

Non-pharmacological approaches are equally important in the management of patients with multi-infarct dementia. The prognosis of multi-infarct dementia is generally poor and the 5-year survival rate is very less compared to other dementia. Moreover, unlike Alzheimer’s disease in which people are susceptible to infections, multi-infarct dementia may directly result into death due to probability of low supply of blood to brain. Despite the evidence that people with multi-infarct dementia improve over time, the condition can become abruptly worse after occurrence of silent strokes.

Geographically, the global Multi-Infarct Dementia (MID) Market can be segmented into four major regions, namely, North America, Europe, Asia-Pacific and Rest of the World. Multi-infarct dementia is second most common type of dementia in North America and Europe, while it is the most common type of dementia in Asia and other parts of the world.

Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=3451

For instance, it accounts for more than 50% of dementia cases in Japan. The prevalence of multi-infarct dementia (MID) is expected to rise drastically in the near future given the exponential rise in geriatric population of the world. Therefore, the global multi-infarct dementia (MID) market is expected to grow rapidly in the developed nations such as the U.S., Canada, Germany, France, and Japan where there is enormous rise in the elderly people.

Some of the key players in the global multi-infarct dementia (MID) market include Eisai, Inc., Pfizer, Inc., Novartis Pharmaceutical Corporation, Janssen Pharmaceuticals, Inc., and Forest Laboratories, Inc.

View Report -

https://www.transparencymarketresearch.com/multi-infarct-dementia-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Multi-Infarct Dementia Market Estimated to Expand at a Robust CAGR by 2020 here

News-ID: 985237 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for MID

Mid Infrared Sensors Market 2017 Emerging Trends
ReportsWeb.com has announced the addition of the “Global Mid Infrared Sensors Industry Market Research 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. In this report, we analyze the Mid Infrared Sensors industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue,
Mid Infrared Lasers Market Technological Advancements 2023
Mid-infrared lasers emit laser like beams and have wavelength ranging from 3 μm to 8 μm. These lasers may either contain some shorter-wavelength laser or a mid-infrared (mid-IR) combined with means required for nonlinear frequency conversion. Mid-infrared lasers are in great demand for variety of applications including polymer and plastic processing, pumping optical parametric oscillators (OPOs), free space communications, remote sensing, laser scalpel, non-invasive medical diagnosis, and spectroscopy. Various defense
Panthera Technologies Expands Mid-Atlantic Presence
Baltimore, MD – March 23, 2016 - Panthera Technologies, a leading Managed Service Provider, Outsource IT Operations and Compliance as a Service firm, is proud to announce the expansion of their Corporate Headquarters based in Owings Mills, Maryland. In partnership with BECO Management Inc. Panthera Technologies more than doubles their current corporate footprint in Owings Mills. “We have had a true partnership with BECO and their Management team over the
Engage PEO Forms Mid-Market Division
Group Created to Address Growing Demand from Large Employers For Strategic HR and Benefits Services. Fort Lauderdale, Fla. -- Engage PEO, a leading professional employer organization providing HR outsourcing solutions to small and mid-sized businesses across the U.S., today announced the formation of a new division dedicated to serve the needs of employers with more than 500 employees. The Mid-Market division was created in response to the growing demand from larger
Texila American University Launches Mid Term Journals
Within a short period of time, Texila American University (TAU) has reached a milestone in providing informative research work through its South American Journal Publications. The broad and informative articles and research topics that have been published in the past one year is the clear proof on how TAU has gone one step ahead in ensuring that people are aware of the various research work done by students and scientist.
Rosendin Electric Expands Mid-Atlantic Operations
Newest Regional Office in Baltimore Brings BIM, Design-Build, and Data Center Expertise to Construction Projects in Maryland, Delaware, and Pennsylvania. Baltimore (April 10, 2014) -- Rosendin Electric (http://www.rosendin.com), the nation's largest private electrical contractor and an employee-owned company, announced the expansion of its East Coast Operations with the opening of an office in Baltimore, Maryland. Headquartered in San Jose, California, Rosendin Electric serves commercial, business and government clients throughout the country. This